ArticleInternational journal of clinical and health psychology : IJCHP
Criterion and construct validity of the Beck Depression Inventory (BDI-II) to measure depression in patients with cancer: The contribution of somatic items.
Article in International journal of clinical and health psychology : IJCHP. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 33 citations in OpenAlex.
- Psychometric properties of the Patient Health Questionnaire-9 and the Generalized Anxiety Disorder-7 in Mexican cancer patients.Palliative & supportive care · 2026Article
- Article
- Cross-sectional and longitudinal functional network alterations associated with subthreshold depressive symptoms in healthy older adults.Frontiers in aging neuroscience · 2026Article
- Cross-Cultural Adaptation and Validation of the Beck Depression Inventory (BDI-II) in the Community Otomi of the Mezquital Valley, Mexico.Healthcare (Basel, Switzerland) · 2025Article
- The Chronic Headache Self-Efficacy Scale: Development and assessment of measurement properties.Headache · 2025Observational
- IRT analysis of the BDI-II for early online depression detection: validation in a Mexican population.Frontiers in psychology · 2025Article
- Differential associations of serum globulin and albumin-globulin ratio with depression in cancer and non-cancer populations: a cross-sectional study.Frontiers in psychiatry · 2025Article
- The relationship between physical activity and depression in college students: the parallel mediating role of mindfulness and life satisfaction.Frontiers in public health · 2025Article
- Mental Disorders, Social Media Addiction, and Academic Performance in Romanian Undergraduate Nursing Students.Journal of clinical medicine · 2024Article
- Elevated neopterin and decreased IL-4, BDNF levels and depression in lymphoma patients receiving R-CHOP chemotherapy.Frontiers in neurology · 2024Article
- Research progress on the psychological burden and intervention measures in cancer patients.Frontiers in psychiatry · 2024Review
- Kazakh version of the beck depression inventory: Validation study in female cancer patients.Heliyon · 2023Article
- Quality of Life, Psychological Distress, and Nutritional Status of Polish Patients with Head and Neck Cancer Treated with Radiotherapy.Journal of clinical medicine · 2023Article
- Depressive symptoms and their severity in a sample with lymphedema: a case-control investigation.Frontiers in psychiatry · 2023Article
- Physical activity and depression of Chinese college students: chain mediating role of rumination and anxiety.Frontiers in psychology · 2023Article
- Assessment of depression in total laryngectomy patients.Brazilian journal of otorhinolaryngologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/Objective: Screening for depression in patients with cancer can be difficult due to overlap between symptoms of depression and cancer. We assessed validity of the Beck Depression Inventory (BDI-II) in this population. Method: Data was obtained in an outpatient neuropsychiatry unit treating patients with and without cancer. Psychometric properties of the BDI-II Portuguese version were assessed separately in 202 patients with cancer, and 376 outpatients with mental health complaints but without cancer. Results: Confirmatory factor analysis suggested a three-factor structure model (cognitive, affective and somatic) provided best fit to data in both samples. Criterion validity was good for detecting depression in oncological patients, with an area under the ROC curve (AUC) of 0.85 (95% confidence interval [CI], 0.76-0.91). A cut-off score of 14 had sensitivity of 87% and specificity of 73%. Excluding somatic items did not significantly change the ROC curve for BDI-II (difference AUCs = 0.002, Conclusions: The BDI-II demonstrated good psychometric properties in patients with cancer, comparable to a population without cancer. Exclusion of somatic items did not affect screening accuracy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.